Adisave Emerges as a Canadian Pioneer in Bio-insurance
TORONTO, Nov. 13, 2012 /CNW/ - Adisave, Canada's first and only provider of adipose (fat)-derived stem cell banking, offers patients a service to collect and preserve stem cells for future use. Adisave has quickly emerged as a pioneer in the area of Bio-Insurance, combining world-class technology and expert medical and scientific professionals with a state-of-the-art facility in Toronto, Canada.
Adisave has developed a rigidly monitored system of collecting, isolating and preserving stem cells that are normally discarded during cosmetic procedures. Generally, adipose-derived stem cells are collected from fat tissue removed during liposuction - however, they can be collected through a number of procedures, without imposing additional risks. Only adult stem cells are collected and preserved - eliminating the controversy associated with embryonic stem cells - and because the cells are the patient's own, there is no risk of rejection. Stem cells may alleviate the harmful effects of heart disease, spinal injury and muscle disorders as well as cancer, arthritis, autoimmune diseases and sports injuries, to name just a few.
"For nearly half a decade, it has been my vision to expand the use of stem cells in medical treatments. We've moved beyond collecting adipose-derived stem cells from liposuction patients and can now offer our services to patients undergoing a number of procedures. Our team was thrilled to successfully launch Adisave - patient and physician interest and feedback have been amazing - the excitement parallels our enthusiasm and commitment to expand our research to help pave the way for the future of medicine," said Dr. Sliwin, Plastic Surgeon and Medical Director of Adisave.
Adisave will be performing two groundbreaking clinical trials. The first involves the use of adipose-derived stem cells to regenerate and repair soft tissue defects and scars, and the second assesses the use of adipose-derived stem cells in the knee joint to regenerate and repair tissue damaged as a result of osteoarthritis. These trials will be performed in strict accordance with Health Canada guidelines and with the methodologies optimized by Adisave's medical and scientific experts. Future applications for adipose-derived stem cells are virtually limitless and banking early provides an insurance policy for years to come.
Adisave is the only adipose-derived stem cell banking facility of this kind in Canada and is a pioneer in the area of Bio-Insurance. Adisave's team is headed by Dr. Sammy Sliwin, MD, FRCSC, Plastic Surgeon and Medical Director Dr. Sliwin's mission, vision and ground-breaking theories are brought to life by Adisave's talented team of internationally recognized experts, which includes its Scientific Director, Dr. Maryam Niapour, and Scientist, Dr. Ilana Platt. For a list of physicians in Adisave's network and for more information, please visit adisave.com
Image with caption: "Adisave, a pioneer in Bio-Insurance, is the only adipose (fat)-derived stem cell banking facility of its kind in Canada, combining world-class technology and expert medical professionals with a state-of-the-art facility in Toronto, Canada. (CNW Group/Adisave)". Image available at: http://photos.newswire.ca/images/download/20121113_C7465_PHOTO_EN_20551.jpg
SOURCE: AdisaveFor further information:
For all media inquiries please contact:
416 781 0151 x46